Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

468 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

MR Biomarkers of Degenerative Brain Disorders Derived From Diffusion Imaging

Andica C, Kamagata K, Hatano T, Saito Y, Ogaki K, Hattori N, Aoki S.

J Magn Reson Imaging. 2020 Dec;52(6):1620-1636. doi: 10.1002/jmri.27019. Epub 2019 Dec 13.

0

0

0

PUBMED

The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin

Aladdin A, Yao Y, Yang C, Kahlert G, Ghani M, Király N, Boratkó A, Uray K, Dittmar G, Tar K.

Biomolecules. 2020 Nov 20;10(11):1581. doi: 10.3390/biom10111581.

0

0

0

PUBMED

Curcumin-Loaded Nanoparticles Based on Amphiphilic Hyaluronan-Conjugate Explored as Targeting Delivery System for Neurodegenerative Disorders

Pepe G, Calce E, Verdoliva V, Saviano M, Maglione V, Di Pardo A, De Luca S.

Int J Mol Sci. 2020 Nov 23;21(22):8846. doi: 10.3390/ijms21228846.

0

0

0

PUBMED

Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot study

McGarry A, Gaughan J, Hackmyer C, Lovett J, Khadeer M, Shaikh H, Pradhan B, Ferraro TN, Wainer IW, Moaddel R.

Sci Rep. 2020 Nov 24;10(1):20490. doi: 10.1038/s41598-020-77526-9.

0

0

0

PUBMED

A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities

Malankhanova T, Suldina L, Grigor'eva E, Medvedev S, Minina J, Morozova K, Kiseleva E, Zakian S, Malakhova A.

J Pers Med. 2020 Nov 9;10(4):E215. doi: 10.3390/jpm10040215.

0

0

0

PUBMED

Loss of TAX1BP1-Directed Autophagy Results in Protein Aggregate Accumulation in the Brain

Sarraf SA, Shah HV, Kanfer G, Pickrell AM, Holtzclaw LA, Ward ME, Youle RJ.

Mol Cell. 2020 Nov 12:S1097-2765(20)30775-9. doi: 10.1016/j.molcel.2020.10.041. Online ahead of print.

0

0

0

PUBMED

Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study

McGarry A, Leinonen M, Kieburtz K, Geva M, Olanow CW, Hayden M.

J Huntingtons Dis. 2020 Nov 6. doi: 10.3233/JHD-200440. Online ahead of print.

0

0

0

PUBMED

[A case of anti-SRY-Related HMG-Box Gene 1 (SOX1) antibody-positive chorea]

Yamagishi T, Inoue K, Ouchi H, Shibano K, Hara K.

Rinsho Shinkeigaku. 2020 Dec 26;60(12):852-856. doi: 10.5692/clinicalneurol.cn-001454. Epub 2020 Nov 20.

0

0

0

PUBMED

Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington's disease

Stepanova P, Srinivasan V, Lindholm D, Voutilainen MH.

Sci Rep. 2020 Nov 5;10(1):19045. doi: 10.1038/s41598-020-75439-1.

0

0

0

PUBMED

Neuroprotective effect of standardized extracts of three Lactuca sativa Linn. varieties against 3-NP induced Huntington's disease like symptoms in rats

Malik J, Kaur S, Karan M, Choudhary S.

Nutr Neurosci. 2020 Nov 8:1-15. doi: 10.1080/1028415X.2020.1841500. Online ahead of print.

0

0

0

PUBMED

Manganese-induced neurotoxicity in cerebellar granule neurons due to perturbation of cell network pathways with potential implications for neurodegenerative disorders

Hernández RB , Carrascal M , Abian J , Michalke B , Farina M , Gonzalez YR , Iyirhiaro GO , Moteshareie H , Burnside D , Golshani A , Suñol C .

Metallomics. 2020 Nov 1;12(11):1656-1678. doi: 10.1039/d0mt00085j. Epub 2020 Sep 7.

0

0

0

PUBMED

Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum

Yang X, Chu SF, Wang ZZ, Li FF, Yuan YH, Chen NH.

Acta Pharmacol Sin. 2020 Nov 19. doi: 10.1038/s41401-020-00558-4. Online ahead of print.

0

0

0

PUBMED

Ferroptosis Mechanisms Involved in Neurodegenerative Diseases

Reichert CO, de Freitas FA, Sampaio-Silva J, Rokita-Rosa L, Barros PL, Levy D, Bydlowski SP.

Int J Mol Sci. 2020 Nov 20;21(22):8765. doi: 10.3390/ijms21228765.

0

0

0

PUBMED

Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction

Colarusso S, De Simone D, Frattarelli T, Andreini M, Cerretani M, Missineo A, Moretti D, Tambone S, Kempf G, Augustin M, Steinbacher S, Munoz-Sanjuan I, Park L, Summa V, Tomei L, Bresciani A, Domingue

Bioorg Med Chem. 2020 Nov 1;28(21):115738. doi: 10.1016/j.bmc.2020.115738. Epub 2020 Aug 30.

0

0

0

PUBMED

Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation

Zhang S, Ma Y, Feng J.

Neural Regen Res. 2020 Nov;15(11):2143-2153. doi: 10.4103/1673-5374.282264.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy